Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Self-associated Indisulam In Phospholipid-based Nanomicelles: A Potential Nanomedicine For Cancer.
H. Cesur, I. Rubinstein, A. Pai, H. Onyüksel
Published 2009 · Materials Science, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
This study aimed to begin development of a nanomedicine containing indisulam solubilized in sterically stabilized micelles (SSMs) composed of DSPE-PEG(2000) or sterically stabilized mixed micelles (SSMMs) composed of DSPE-PEG(2000) plus egg phosphatidylcholine. Micelles were prepared by co-precipitation and reconstitution of drug and lipids. Particle size distributions of micellar formulations were determined by quasi-elastic light scattering. Amounts of solubilized drug were determined by reverse-phase high-performance liquid chromatography (RP-HPLC). In vitro cytotoxicity of indisulam in nanocarrier was determined on the MCF-7 cell line by the National Cancer Institute-developed sulforhodamine B assay. Optimal solubilized indisulam concentrations in 5 mM total lipid were 10 microg/mL for SSMMs and 400 microg/mL for SSMs. HPLC results demonstrated that the encapsulation capacity of both micelles was over 95%. In vitro studies showed that indisulam in micellar system was more effective than free indisulam. The optimized formulation was successfully freeze-dried without any addition of lyoprotectants or cryoprotectants. We conclude that SSMs are a promising nanocarrier for indisulam, and indisulam-SSMs should be developed further as a novel targeted nanomedicine.
This paper references
Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-early clinical studies group (ECSG).
C. Punt (2001)
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.
A. Gabizon (2004)
Capecitabine in combination with novel targeted agents in the management of metastatic breast cancer: underlying rationale and results of clinical trials.
D. Tripathy (2007)
Profiling novel sulfonamide antitumor agents with cell-based phenotypic screens and array-based gene expression analysis.
A. Yokoi (2002)
Optimization of the sulforhodamine B colorimetric assay.
K. Papazisis (1997)
Sulforhodamine B colorimetric assay for cytotoxicity screening
V. Vichai (2006)
Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water-Soluble Drugs
J. Dressman (2007)
Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancer.
E. Raymond (2002)
SATURABLE BINDING OF INDISULAM TO PLASMA PROTEINS AND DISTRIBUTION TO HUMAN ERYTHROCYTES
A. Zandvliet (2006)
Polyethylene Glycol-Diacyllipid Micelles Demonstrate Increased Accumulation in Subcutaneous Tumors in Mice
A. Lukyanov (2004)
In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.
B. Ashok (2004)
Sterically Stabilized Phospholipid Mixed Micelles: In Vitro Evaluation as a Novel Carrier for Water-Insoluble Drugs
A. Krishnadas (2004)
Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX.
F. Abbate (2004)
Mechanisms of Action of the Novel Sulfonamide Anticancer Agent E7070 on Cell Cycle Progression in Human Non-Small Cell Lung Cancer Cells
K. Fukuoka (2004)
Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days
Y. Yamada (2005)
Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
O. Koo (2005)
A phase I and pharmacokinetic study of indisulam in combination with carboplatin
C. Dittrich (2007)
Solubility and stability of lorazepam in bile salt/soya phosphatidylcholine-mixed micelles.
M. A. Hammad (1999)
Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles.
S. B. Lim (2008)
A Novel Formulation of VIP in Sterically Stabilized Micelles Amplifies Vasodilation In Vivo
H. Önyüksel (2004)
Lipid-derivatized poly(ethylene glycol) micellar formulations of benzoporphyrin derivatives.
J. X. Zhang (2003)
Phase II study of E7070 in patients with metastatic melanoma.
J. F. Smyth (2005)
Role of nanotechnology in targeted drug delivery and imaging: a concise review.
O. Koo (2005)
Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a onehour infusion every three weeks in patients with advanced cancer
E Raymond (2002)
a concise review
OM Koo (2009)
E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo.
Y. Ozawa (2001)
Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle.
T. Owa (1999)
Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.
A. Lukyanov (2004)
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays
N. Nakatsu (2005)
This paper is referenced by
Improved self-assembled micelles based on supercritical fluid technology as a novel oral delivery system for enhancing germacrone oral bioavailability.
Xuefeng Hou (2019)
Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations
M. Sahib (2011)
Phospholipid-based Nanomicelles in Cancer Nanomedicine
H. Onyuksel (2011)
Intestinal absorption of fluorescently labeled nanoparticles.
S. Simović (2015)
Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer
Y. Gu (2016)
Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
Wen-hao Li (2020)
Transmucosal and Ocular Drug Delivery
Vasant V. Ranade (2011)
Lipid-based nanoformulations for peptide delivery.
N. Matougui (2016)
The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery.
Hongjuan Yao (2011)
A New Lipid-Based Nano Formulation of Vinorelbine
F. Bahadori (2014)
A pH-Sensitive Nanocarrier for Tumor Targeting
Ligang Chen (2016)
Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
Baomei Zhang (2017)
Self‐assembled amphiphilic core‐shell nanocarriers in line with the modern strategies for brain delivery
Reham S. Elezaby (2017)
Nanomedicines for inflammatory diseases.
Fatima Khaja (2012)
Formulation and Characterization of Phospholipid Based Micelles: A Potential Carrier for Cancer
Mayank Chaudhari (2019)
A novel antineoplastic nano-lipobubble drug delivery system for passively targeted ovarian cancer therapy
Derusha Frank (2015)
Nanoparticles: Cancer Management Applications
Shyamasree Ghosh (2017)
Drugs That Inhibit Signalling Pathways for Tumor Cell Growth and Proliferation
C. Avendaño (2008)
Developing health service delivery in a poor and marginalised community in North West Pakistan
Rajneet Kaur Khurana (2019)
Drugs That Inhibit Signaling Pathways for Tumor Cell Growth and Proliferation: Kinase Inhibitors
C. Avendaño (2015)
pH-Responsive Nanoparticles Targeted to Lungs for Improved Therapy of Acute Lung Inflammation/Injury.
C. Zhang (2019)
Peptide delivery using phospholipid micelles.
A. Banerjee (2012)
Improvement of drug safety by the use of lipid-based nanocarriers.
S. B. Lim (2012)
Multidynamic Liposomes in Nanomedicine: Technology, Biology, Applications, and Disease Targeting
S. Ghosh (2015)
Incorporation of Beclomethasone Dipropionate into Polyethylene Glycol‐Diacyl Lipid Micelles as a Pulmonary Delivery System
Mohanad Naji Sahib (2012)
A Novel Anti-Diabetic Peptide Nanomedicine Against Pancreatogenic Diabetes
Amrita Banerjee (2012)
Doxorubicin and rhein loaded nanomicelles attenuates multidrug resistance in human ovarian cancer.
Nana Han (2018)
Sterically Stabilized Phospholipid Micelles Reduce Activity of a Candidate Antimicrobial Wound Healing Adjunct
R. Williams (2012)
VIP-targeted cytotoxic nanomedicine for breast cancer
Aparna Dagar (2012)
Radiation Protection with Nanoparticles
C. Baker (2011)
Drug Delivery Using Nanocarriers: Indian Perspective
S. Gupta (2012)
Peptide-micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension.
Nilesh I. Gupta (2014)See more